Building Future Ready PI

Growth momentum to continue in FY23 Pi Inspired by Science Domestic: Focus on portfolio diversification with launch of novel offerings CSM Export: R&D focused approach to drive incremental business Efforts to drive strategic initiatives continues · Strong demand is expected for insecticides, fungicides, herbicides and bio-nutrients on the back of normal monsoon predictions Commodity prices remain robust owing to global demand 5 new products scheduled to be launched in FY23 Continued scale up in demand of some of the existing products Commercialization of 7 new molecules planned in FY23 Momentum in new enquiries and conversion to continue Drive higher capital efficiency in FY23 with focused program to reduce Trade Working Capital 2 new process innovations to be commercialized in FY23 Evaluation of inorganic growth opportunities in pharma continues, both domestic and international options being evaluated PI's product & research efforts yielding promising results Discussions continues with global innovators for development partnership of 2 promising leads; one novel fungicide and a novel broad spectrum insecticide having sizable potential market opportunity ...Confident of delivering 18%-20% revenue growth with continued improvement in margins and returns 22

View entire presentation